Plasmid-mediated quinolones resistance in clinically important bacteria

Authors

M Omidvar Panah1, M Najafi1, Amir Peymani1,*
1Medical Microbiology Research Center, Qazvin University of Medical Sciences, Qazvin, Iran
*Corresponding Author: Medical Microbiology Research Center, Qazvin University of Medical Sciences, Qazvin, Iran Email: [email protected]

Journal of Inflammatory Diseases:Vol. 22, issue 2; 90-99
Published online:Jul 31, 2018
Article type:Review Article
How to Cite:Omidvar Panah M, Najafi M, Peymani A. Plasmid-mediated quinolones resistance in clinically important bacteria. J Inflamm Dis. 2024;22(2):e156086. doi:

Abstract

Quinolones are synthetic and commonly used antibiotics for treatment of multiple clinical infections in the world. Quinolones are clinically important antibiotics, as an ideal component, because of high potency, broad-spectrum activity, good bioavailability and a potentially low incidence of side-effects. These antibiotics are not originated from biological source. In addition to chromosomal mutations in the target genes which confer resistance to these antibiotics, in recent years, plasmids-mediated quinolone resistance (PMQR) have made difficult to treat infections caused by resistant organisms. PMQR plays a very important role in resistance to these antibiotics due to the rapid spread between the bacteria. So far, three types of PMQR have been identified, including the aac(6')-Ib-cr, the qepA efflux pump and the qnr proteins. In this research, the role of qnr proteins in the development of drug resistance to the quinolone compounds has been studied.

Copyright

© 2024, Journal of Inflammatory Diseases. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.

Similar Articles

26
Apr
2017

The Impact of Mutations in Topoisomerase Genes and the Plasmid-Mediated Quinolone Resistance (PMQR) Determinants on the Resistance to Fluoroquinolones in Klebsiella pneumoniae

Alisha Akya,
Roya Chegene Lorestani,
Azam Elahi,
Keyghobad Ghadiri

Akya A, Chegene Lorestani R, Elahi A, Ghadiri K. The Impact of Mutations in Topoisomerase Genes and the Plasmid-Mediated Quinolone Resistance (PMQR) Determinants on the Resistance to Fluoroquinolones in Klebsiella pneumoniae. Arch Clin Infect Dis. 2017;12(4):e57290. doi: https://doi.org/10.5812/archcid.57290

25
Jul
2015

Prevalence of Plasmid-Mediated Quinolone Resistance (PMQR) Determinants Among Extended Spectrum Beta-Lactamases (ESBL)-Producing Isolates of Escherichia coli and Klebsiella pneumoniae in Aleppo, Syria

Omar Alheib,
Rawaa Al Kayali,
M. Yaser Abajy

Alheib O, Al Kayali R, Abajy MY. Prevalence of Plasmid-Mediated Quinolone Resistance (PMQR) Determinants Among Extended Spectrum Beta-Lactamases (ESBL)-Producing Isolates of Escherichia coli and Klebsiella pneumoniae in Aleppo, Syria. Arch Clin Infect Dis. 2015;10(3):e20631. doi: https://doi.org/10.5812/archcid.20631

17
Aug
2022
Prevalence of Plasmid-Mediated Quinolone Resistance Genes and Molecular Typing of Klebsiella pneumoniae Isolates from Blood Cultures in Milad Hospital, Tehran, Iran, Within 2018 - 2019

Prevalence of Plasmid-Mediated Quinolone Resistance Genes and Molecular Typing of Klebsiella pneumoniae Isolates from Blood Cultures in Milad Hospital, Tehran, Iran, Within 2018 - 2019

Maryam Ghane,
Laleh Babaeekhou,
Morteza Asgharifard

Ghane M, Babaeekhou L, Asgharifard M. Prevalence of Plasmid-Mediated Quinolone Resistance Genes and Molecular Typing of Klebsiella pneumoniae Isolates from Blood Cultures in Milad Hospital, Tehran, Iran, Within 2018 - 2019. Jundishapur J Microbiol. 2022;15(7):e124054. doi: https://doi.org/10.5812/jjm-124054

16
Mar
2025
Investigating the Frequency of Genotypic and Phenotypic Resistance to Plasmid-Mediated Ciprofloxacin in Clinical Isolates of Klebsiellapneumoniae in Ardabil

Investigating the Frequency of Genotypic and Phenotypic Resistance to Plasmid-Mediated Ciprofloxacin in Clinical Isolates of Klebsiellapneumoniae in Ardabil

Malek Namaki Kheljan,
Maliheh Hasanzadeh,
Zohreh Neyestani,
Mohammad Ali Jafarizare,
Kazem Nejati-Koshki,
Mehdi Asghari Vostakoli

Namaki Kheljan M, Hasanzadeh M, Neyestani Z, Jafarizare MA, Nejati-Koshki K, et al. Investigating the Frequency of Genotypic and Phenotypic Resistance to Plasmid-Mediated Ciprofloxacin in Clinical Isolates of Klebsiellapneumoniae in Ardabil. Arch Clin Infect Dis. 2025;20(3):e148969. doi: https://doi.org/10.5812/archcid-148969

20
Aug
2018
A Survey of gyrA Target-Site Mutation and qnr Genes among Clinical Isolates of Escherichia coli in the North of Iran

A Survey of gyrA Target-Site Mutation and qnr Genes among Clinical Isolates of Escherichia coli in the North of Iran

Setareh Yousefi,
Ali Mojtahedi,
Mohammad Shenagari

Yousefi S, Mojtahedi A, Shenagari M. A Survey of gyrA Target-Site Mutation and qnr Genes among Clinical Isolates of Escherichia coli in the North of Iran. Jundishapur J Microbiol. 2018;11(9):e67293. doi: https://doi.org/10.5812/jjm.67293

More by these authors

M Omidvar PanahPubMedScholar
Amir PeymaniPubMedScholar
Share
Cited by
Metrics